Altoprev Articles
Andrx' 4th-qtr 2005 income drops 16%
27 March 2006
First Horizon buys two Andrx drugs for $85M
14 March 2005
US Medicare discount Rx plan web site introduces price comparisons
27 September 2004
Kos settles with Andrx over Advicor
21 June 2004
New use for Altocor approvable, says FDA
15 July 2002
Andrx gets US OK for branded lipid-lowerer
1 July 2002
Andrx gets tentative OK for lovastatin brand
11 February 2002
Geneva returns drug rights to Andrx
25 October 2001
Showing 1-8 of 8 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
